Correlation Between Genfit and Biocardia
Can any of the company-specific risk be diversified away by investing in both Genfit and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genfit and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genfit and Biocardia, you can compare the effects of market volatilities on Genfit and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genfit with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genfit and Biocardia.
Diversification Opportunities for Genfit and Biocardia
Poor diversification
The 3 months correlation between Genfit and Biocardia is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Genfit and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Genfit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genfit are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Genfit i.e., Genfit and Biocardia go up and down completely randomly.
Pair Corralation between Genfit and Biocardia
Given the investment horizon of 90 days Genfit is expected to under-perform the Biocardia. But the stock apears to be less risky and, when comparing its historical volatility, Genfit is 1.26 times less risky than Biocardia. The stock trades about -0.13 of its potential returns per unit of risk. The Biocardia is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 257.00 in Biocardia on September 25, 2024 and sell it today you would lose (56.00) from holding Biocardia or give up 21.79% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Genfit vs. Biocardia
Performance |
Timeline |
Genfit |
Biocardia |
Genfit and Biocardia Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genfit and Biocardia
The main advantage of trading using opposite Genfit and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genfit position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.Genfit vs. Fate Therapeutics | Genfit vs. Caribou Biosciences | Genfit vs. Karyopharm Therapeutics | Genfit vs. X4 Pharmaceuticals |
Biocardia vs. Aerovate Therapeutics | Biocardia vs. Adagene | Biocardia vs. Acrivon Therapeutics, Common | Biocardia vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |